Literature DB >> 26179481

The Noscapine Chronicle: A Pharmaco-Historic Biography of the Opiate Alkaloid Family and its Clinical Applications.

Padmashree C G Rida1,2, Dillon LiVecche2, Angela Ogden2, Jun Zhou3, Ritu Aneja2.   

Abstract

Given its manifold potential therapeutic applications and amenability to modification, noscapine is a veritable "Renaissance drug" worthy of commemoration. Perhaps the only facet of noscapine's profile more astounding than its versatility is its virtual lack of side effects and addictive properties, which distinguishes it from other denizens of Papaver somniferum. This review intimately chronicles the rich intellectual and pharmacological history behind the noscapine family of compounds, the length of whose arms was revealed over decades of patient scholarship and experimentation. We discuss the intriguing story of this family of nontoxic alkaloids, from noscapine's purification from opium at the turn of the 19th century in Paris to the recent torrent of rationally designed analogs with tremendous anticancer potential. In between, noscapine's unique pharmacology; impact on cellular signaling pathways, the mitotic spindle, and centrosome clustering; use as an antimalarial drug and cough suppressant; and exceptional potential as a treatment for polycystic ovarian syndrome, strokes, and diverse malignancies are catalogued. Seminal experiments involving some of its more promising analogs, such as amino-noscapine, 9-nitronoscapine, 9-bromonoscapine, and reduced bromonoscapine, are also detailed. Finally, the bright future of these oftentimes even more exceptional derivatives is described, rounding out a portrait of a truly remarkable family of compounds.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  antineoplastic drugs; centrosome declustering drugs; microtubule targeting drugs; noscapine; noscapinoids

Mesh:

Substances:

Year:  2015        PMID: 26179481      PMCID: PMC4778555          DOI: 10.1002/med.21357

Source DB:  PubMed          Journal:  Med Res Rev        ISSN: 0198-6325            Impact factor:   12.944


  95 in total

1.  Opium alkaloid noscapine is an antitumor agent that arrests metaphase and induces apoptosis in dividing cells.

Authors:  K Ye; Y Ke; N Keshava; J Shanks; J A Kapp; R R Tekmal; J Petros; H C Joshi
Journal:  Proc Natl Acad Sci U S A       Date:  1998-02-17       Impact factor: 11.205

2.  Treatment of hormone-refractory breast cancer: apoptosis and regression of human tumors implanted in mice.

Authors:  Ritu Aneja; Jun Zhou; Binfei Zhou; Ramesh Chandra; Harish C Joshi
Journal:  Mol Cancer Ther       Date:  2006-09       Impact factor: 6.261

3.  Cloning and characterization of canadine synthase involved in noscapine biosynthesis in opium poppy.

Authors:  Thu-Thuy T Dang; Peter J Facchini
Journal:  FEBS Lett       Date:  2013-12-04       Impact factor: 4.124

4.  Noscapine induces mitochondria-mediated apoptosis in human colon cancer cells in vivo and in vitro.

Authors:  Zi-Rong Yang; Meng Liu; Xiu-Lan Peng; Xiao-Fei Lei; Ji-Xiang Zhang; Wei-Guo Dong
Journal:  Biochem Biophys Res Commun       Date:  2012-04-22       Impact factor: 3.575

5.  Noscapine suppresses angiotensin converting enzyme inhibitors-induced cough.

Authors:  Ahmad Mooraki; Aria Jenabi; Mosadegh Jabbari; Mohammad I Zolfaghari; Sahar Z Javanmardi; Masoud Mahmoudian; Bahar Bastani
Journal:  Nephrology (Carlton)       Date:  2005-08       Impact factor: 2.506

Review 6.  The anti-cancer activity of noscapine: a review.

Authors:  Massoud Mahmoudian; Parvaneh Rahimi-Moghaddam
Journal:  Recent Pat Anticancer Drug Discov       Date:  2009-01       Impact factor: 4.169

7.  Inhibitory effects of noscapine on dopamine biosynthesis in PC12 cells.

Authors:  J S Shin; S S Lee; M K Lee
Journal:  Arch Pharm Res       Date:  1997-10       Impact factor: 4.946

8.  Epithelial transport of noscapine across cell monolayer and influence of absorption enhancers on in vitro permeation and bioavailability: implications for intestinal absorption.

Authors:  Mahavir B Chougule; Apurva R Patel; Ram Patlolla; Tanise Jackson; Mandip Singh
Journal:  J Drug Target       Date:  2014-04-14       Impact factor: 5.121

9.  Pharmacokinetic properties of noscapine.

Authors:  B Dahlström; T Mellstrand; C G Löfdahl; M Johansson
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

10.  Enhanced noscapine delivery using estrogen-receptor-targeted nanoparticles for breast cancer therapy.

Authors:  Jitender Madan; Sushma R Gundala; Yoganjaneyulu Kasetti; Prasad V Bharatam; Ritu Aneja; Anju Katyal; Upendra K Jain
Journal:  Anticancer Drugs       Date:  2014-07       Impact factor: 2.248

View more
  15 in total

1.  Interaction of OTC drug noscapine and acenocoumarol and phenprocoumon.

Authors:  Bianca Lokhorst; Leàn Rolfes; Naomi T Jessurun
Journal:  Br J Clin Pharmacol       Date:  2019-02-26       Impact factor: 4.335

Review 2.  Current status and contemporary approaches to the discovery of antitumor agents from higher plants.

Authors:  Garima Agarwal; Peter J Blanco Carcache; Ermias Mekuria Addo; A Douglas Kinghorn
Journal:  Biotechnol Adv       Date:  2019-01-08       Impact factor: 14.227

3.  Repositioning antispasmodic drug Papaverine for the treatment of chronic myeloid leukemia.

Authors:  Phani Krishna Parcha; Sailu Sarvagalla; Cheemala Ashok; S J Sudharshan; Madhu Dyavaiah; Mohane Selvaraj Coumar; Baskaran Rajasekaran
Journal:  Pharmacol Rep       Date:  2021-01-03       Impact factor: 3.024

4.  Noscapine chemosensitization enhances docetaxel anticancer activity and nanocarrier uptake in triple negative breast cancer.

Authors:  Ravi Doddapaneni; Ketan Patel; Nusrat Chowdhury; Mandip Singh
Journal:  Exp Cell Res       Date:  2016-05-10       Impact factor: 3.905

5.  Combination therapy for cerebral ischemia: do progesterone and noscapine provide better neuroprotection than either alone in the treatment?

Authors:  Manisha Kawadkar; Avinash S Mandloi; Nidhi Singh; Rajesh Mukharjee; Vipin V Dhote
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2022-01-06       Impact factor: 3.000

6.  Bitter taste receptors are expressed in human epithelial ovarian and prostate cancers cells and noscapine stimulation impacts cell survival.

Authors:  Louis T P Martin; Mark W Nachtigal; Tamara Selman; Elaine Nguyen; Jayme Salsman; Graham Dellaire; Denis J Dupré
Journal:  Mol Cell Biochem       Date:  2018-10-22       Impact factor: 3.396

7.  Noscapine alleviates cerebral damage in ischemia-reperfusion injury in rats.

Authors:  Manisha Kawadkar; Avinash S Mandloi; Vidhu Saxena; Chetana Tamadaddi; Chandan Sahi; Vipin V Dhote
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2020-10-27       Impact factor: 3.000

Review 8.  Biosynthesis and synthetic biology of psychoactive natural products.

Authors:  Cooper S Jamieson; Joshua Misa; Yi Tang; John M Billingsley
Journal:  Chem Soc Rev       Date:  2021-06-21       Impact factor: 60.615

9.  Noscapine Acts as a Protease Inhibitor of In Vitro Elastase-Induced Collagen Deposition in Equine Endometrium.

Authors:  Ana Amaral; Carina Fernandes; Anna Szóstek-Mioduchowska; Maria Rosa Rebordão; Dariusz Jan Skarzynski; Graça Ferreira-Dias
Journal:  Int J Mol Sci       Date:  2021-05-19       Impact factor: 5.923

10.  Engineering biosynthesis of the anticancer alkaloid noscapine in yeast.

Authors:  Yanran Li; Christina D Smolke
Journal:  Nat Commun       Date:  2016-07-05       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.